|Day Low/High||331.24 / 334.03|
|52 Wk Low/High||223.02 / 337.73|
The trading panel expressed their dismay at the severe drop in the market.
Analyst upgrades C.R. Bard shares to 'buy,' expecting company to reach sales growth goal
Medtronic posts a steep earnings decline on a slew of charges, though its sales grew in the first quarter.
C.R. Bard's 1st-quarter profit rises 44 percent as restructuring program reduces costs
C.R. Bard CEO Timothy Ring gets $10.5M in 2008 compensation, up 9 percent from year before
Cramer likes its balance sheet and managment.
The UMB Scout Stock Fund prepares for changes in the health-care industry under a new administration.
The oil giant reported a record quarterly profit despite the drop in crude oil prices.
The company has a flourishing business in stents, catheters and other medical devices, Cramer says.
Companies such as C.R. Bard and Becton Dickinson might not be the most glamorous names, but their slow and steady performances may win the race.
Here's a list of companies that have recently announced buybacks.
To help offset the Fed's 'intransigence,' Cramer offers his 'Three Bs' defensive portfolio.
There's no need to get aggressive in either direction in the current environment.
A viewer learns Cramer's take on medical devices company C.R. Bard.
Cramer says look past the hits taken by Intel and Yahoo! for good tech stocks.
Among companies ripe for corporate conquest are UST and Bard, Cramer says.
Food, health care and consumer nondurables are moving forward in slick conditions.
The market needs a day or two longer to resolve short-term direction.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.